Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin H Kim

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology|December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocolEdwin H Kim, Stacie M Jones, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2022
Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food AllergyR Sharon Chinthrajah, Stacie M Jones, Edwin H Kim, et al.
The Journal of Allergy and Clinical Immunology. Global|February 3, 2025
ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trialEdwin H Kim, Warner W Carr, Amal H Assa'ad, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 3, 2017
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ Andrew Bird, Jonathan M Spergel, Stacie M Jones, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergyEdwin H Kim, Tamara T Perry, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohortsM Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveBrian P Vickery, Jelena P Berglund, Caitlin M Burk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical TrialMarion Groetch, Kim Mudd, Margaret Woch, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology|December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocolEdwin H Kim, Stacie M Jones, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2022
Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food AllergyR Sharon Chinthrajah, Stacie M Jones, Edwin H Kim, et al.
The Journal of Allergy and Clinical Immunology. Global|February 3, 2025
ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trialEdwin H Kim, Warner W Carr, Amal H Assa'ad, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 3, 2017
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ Andrew Bird, Jonathan M Spergel, Stacie M Jones, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergyEdwin H Kim, Tamara T Perry, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohortsM Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveBrian P Vickery, Jelena P Berglund, Caitlin M Burk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical TrialMarion Groetch, Kim Mudd, Margaret Woch, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
Pageof 10